NO171412C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater

Info

Publication number
NO171412C
NO171412C NO884223A NO884223A NO171412C NO 171412 C NO171412 C NO 171412C NO 884223 A NO884223 A NO 884223A NO 884223 A NO884223 A NO 884223A NO 171412 C NO171412 C NO 171412C
Authority
NO
Norway
Prior art keywords
oxatatiolan
ditiolander
derivatives
preparation
therapeutic active
Prior art date
Application number
NO884223A
Other languages
English (en)
Norwegian (no)
Other versions
NO171412B (no
NO884223L (no
NO884223D0 (no
Inventor
James Ronald Deason
Michael Allan Stealey
Richard Mathias Weier
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/100,685 external-priority patent/US4808729A/en
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO884223D0 publication Critical patent/NO884223D0/no
Publication of NO884223L publication Critical patent/NO884223L/no
Publication of NO171412B publication Critical patent/NO171412B/no
Publication of NO171412C publication Critical patent/NO171412C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO884223A 1987-09-24 1988-09-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater NO171412C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/100,685 US4808729A (en) 1987-09-24 1987-09-24 Leukotriene LTD4 and LTB4 antagonists
US07/241,265 US4923891A (en) 1987-09-24 1988-09-09 Leukotriene LTD4 and LTB4 antagonists

Publications (4)

Publication Number Publication Date
NO884223D0 NO884223D0 (no) 1988-09-23
NO884223L NO884223L (no) 1989-03-28
NO171412B NO171412B (no) 1992-11-30
NO171412C true NO171412C (no) 1993-03-10

Family

ID=26797440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884223A NO171412C (no) 1987-09-24 1988-09-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater

Country Status (14)

Country Link
US (1) US4923891A (OSRAM)
EP (1) EP0308956B1 (OSRAM)
JP (1) JPH01132577A (OSRAM)
KR (1) KR890005082A (OSRAM)
AU (1) AU610246B2 (OSRAM)
DE (1) DE3878806T2 (OSRAM)
DK (1) DK530888A (OSRAM)
ES (1) ES2045052T3 (OSRAM)
FI (1) FI884377A7 (OSRAM)
GR (1) GR3007858T3 (OSRAM)
IL (1) IL87800A (OSRAM)
NO (1) NO171412C (OSRAM)
NZ (1) NZ226318A (OSRAM)
PT (1) PT88580B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5579409A (en) * 1991-09-27 1996-11-26 E. I. Du Pont De Nemours And Company Methods for determining the exterior points of an object in a background
US6342510B1 (en) 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
DE69733338T2 (de) 1996-02-13 2006-03-16 G.D. Searle & Co., Chicago Zubereitungen, enthaltend einen cyclooxygenase-2-inhibitor und einen leukotrien-b4-rezeptor-antagonisten
EP1090916B1 (en) * 1999-10-06 2003-09-03 Dainippon Ink And Chemicals, Inc. 4-methylene-1,3-dioxolanes having functional groups
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
CN101346067B (zh) * 2005-11-22 2013-03-27 塞格提斯有限公司 甘油乙酰丙酸酯缩酮及其用途
BRPI0818370A2 (pt) * 2007-10-09 2017-05-16 Segetis Inc métodos de fabricar cetais e acetais
CN102239156B (zh) 2008-09-25 2014-10-15 塞格提斯有限公司 缩酮酯衍生物
JP5882204B2 (ja) 2009-06-22 2016-03-09 サジティス・インコーポレイテッド ケタール化合物およびそれらの使用
BR112012028717A2 (pt) 2010-05-10 2016-07-19 Segetis Inc formulações de cuidados pessoais contendo ésteres de cetal alquílicos e métodos de fabricação
EP2601184B1 (en) 2010-08-03 2015-12-16 Segetis, Inc. Methods for the manufacture of ketals
BR112013002991A2 (pt) 2010-08-12 2016-08-16 Segetis Inc composições de revestimento de látex incluindo carboxiéster cetal coalescentes, métodos de fabricação e usos dos mesmos
US8828917B2 (en) 2010-08-12 2014-09-09 Segetis, Inc. Carboxy ester ketal removal compositions, methods of manufacture, and uses thereof
EP2613760A2 (en) 2010-09-07 2013-07-17 Segetis, Inc. Compositions for dyeing keratin fibers
CN103097604A (zh) 2010-09-13 2013-05-08 赛格提斯有限公司 织物软化剂组合物及其制造方法
WO2012054505A2 (en) 2010-10-18 2012-04-26 Segetis, Inc. Water reducible coating compositions including carboxy ester ketals, methods of manufacture, and uses thereof
WO2014047428A1 (en) 2012-09-21 2014-03-27 Segetis, Inc. Cleaning, surfactant, and personal care compositions
US9156809B2 (en) 2012-11-29 2015-10-13 Segetis, Inc. Carboxy ester ketals, methods of manufacture, and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2839445A (en) * 1954-01-11 1958-06-17 Du Pont Fungicidal and anti-oxidant compositions comprising 1, 3-dithiolanes
FR1448340A (fr) * 1964-07-09 1966-08-05 Boehringer Sohn Ingelheim Procédé pour fabriquer des nouveaux 1, 3-dioxolanes
FR1445013A (fr) * 1964-07-09 1966-07-08 Thomae Gmbh Dr K Procédé pour fabriquer des nouveaux acides dioxolano-2-carboxyliques
FR4493M (OSRAM) * 1964-07-09 1966-10-10
GB1427918A (en) * 1972-05-26 1976-03-10 Shell Int Research Herbicidal glycerol acetals
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
FI884377L (fi) 1989-03-25
JPH01132577A (ja) 1989-05-25
US4923891A (en) 1990-05-08
AU610246B2 (en) 1991-05-16
NO171412B (no) 1992-11-30
DK530888A (da) 1989-03-25
PT88580B (pt) 1992-11-30
IL87800A0 (en) 1989-03-31
IL87800A (en) 1992-12-01
EP0308956A3 (en) 1990-06-13
NO884223L (no) 1989-03-28
EP0308956A2 (en) 1989-03-29
NO884223D0 (no) 1988-09-23
KR890005082A (ko) 1989-05-11
NZ226318A (en) 1991-08-27
GR3007858T3 (OSRAM) 1993-08-31
PT88580A (pt) 1988-10-01
EP0308956B1 (en) 1993-03-03
FI884377A0 (fi) 1988-09-23
ES2045052T3 (es) 1994-01-16
DK530888D0 (da) 1988-09-23
DE3878806D1 (de) 1993-04-08
FI884377A7 (fi) 1989-03-25
AU2274188A (en) 1989-04-06
DE3878806T2 (de) 1993-07-01

Similar Documents

Publication Publication Date Title
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater.
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO900972L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.